PLK1 inhibition dampens NLRP3 inflammasome–elicited response in inflammatory disease models
Unabated activation of the NLR family pyrin domain–containing 3 (NLRP3) inflammasome is linked with the pathogenesis of various inflammatory disorders. Polo-like kinase 1 (PLK1) has been widely studied for its role in mitosis. Here, using both pharmacological and genetic approaches, we demonstrate t...
Main Authors: | Marta Baldrighi, Christian Doreth, Yang Li, Xiaohui Zhao, Emily Warner, Hannah Chenoweth, Kamal Kishore, Yagnesh Umrania, David-Paul Minde, Sarah Thome, Xian Yu, Yuning Lu, Alice Knapton, James Harrison, Murray Clarke, Eicke Latz, Guillermo de Cárcer, Marcos Malumbres, Bernhard Ryffel, Clare Bryant, Jinping Liu, Kathryn S. Lilley, Ziad Mallat, Xuan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-11-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI162129 |
Similar Items
-
Plk1 overexpression induces chromosomal instability and suppresses tumor development
by: Guillermo de Cárcer, et al.
Published: (2018-08-01) -
Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation [version 1; referees: 2 approved]
by: Tomasz Próchnicki, et al.
Published: (2016-06-01) -
gene silencing dampens bone marrow stromal cell hypertrophy, but it also dampens chondrogenesis
by: Rose Ann G Franco, et al.
Published: (2023-06-01) -
The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma
by: Zhiqi Zhang, et al.
Published: (2023-11-01) -
Tools to discriminate between targets of CK2 vs PLK2/PLK3 acidophilic kinases
by: M. Salvi, et al.
Published: (2012-07-01)